A target trial emulation was conducted to assess the effectiveness of recombinant zoster vaccine (RZV) accounting for prior receipt of live zoster vaccine (ZVL) and immunocompetence. The study found ...

Please provide your email address to receive an email when new articles are posted on . Antiviral treatment remains a cornerstone in preventing recurrence and reducing post-herpetic pain in herpes ...

The incidence of herpes zoster and herpes zoster ophthalmicus increase after age 50, and both are associated with an increased risk of cardiovascular complications. For patients ages 50 and older, the ...

In adults aged 50 years or older, the 2-dose recombinant zoster vaccine is linked to reduced risk for HZO, acute myocardial infarction, and stroke. HealthDay News — Two doses of recombinant zoster ...

"These data suggest that health benefits of RZV immunization may extend beyond the well-described prevention of herpes zoster and postherpetic neuralgia." HealthDay News — Two doses of recombinant ...

TUESDAY, Aug. 19, 2025 (HealthDay News) -- Two doses of recombinant zoster vaccine (RZV) are associated with a reduced risk for herpes zoster ophthalmicus (HZO), acute myocardial infarction, and ...

This case is quoted, p. 78, in Dr. H. F. Damon's little book on Neurosis of the Skin, thus: "Dr. Williams, of Boston, has observed a case of inflammation of the eye from zoster frontalis. The ...

Vaccination against shingles may come with a surprising perk. A recent study posits that the vaccine for herpes zoster, also known as shingles, protects against more than a painful, angry rash.

BOSTON--(BUSINESS WIRE)--Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the ...